It all started in 1960 when two French families with furniture shops, helmed by the Roches and the Chouchans, decided to join ...

Since the 2023 financing round, Flare’s lead program FX-909 has moved into a phase 1 clinical trial for patients with ...

In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...

After forming a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more. In a new deal potentially worth more than $1 billion, Roche is paying Dyno $50 million upfront to ...

Roche ROG-1.53%decrease; red down pointing triangle confirmed its profit outlook for the year after its eye drug Vabysmo, multiple-sclerosis treatment Ocrevus and hemophilia injection Hemlibra ...

We hope you have a wonderful day, and please do keep in touch. … An experimental Alzheimer’s therapy from Roche successfully cleared a protein that’s a hallmark of the disease from patients ...

In the winding, ivy-draped streets of Trastevere, Rome, Zazie Gnecchi Ruscone is hand-painting sharp geometric patterns on a ...

Roche has reported early-stage clinical data with an oral GLP-1 agonist acquired as part of its $3.1 billion takeover of Carmot Therapeutics as it tries to catch up with the leaders in the fast ...

La Roche-Posay serums are some of our favourites ... we’ve spotted a reduction on one of the brand’s hyperpigmentation bestsellers – the melaB3 serum (was £48, now £38.40, Lookfantastic ...

generally occupied by luxury and high-end contemporary furniture brands like Roche Bobois and Maurice Villency. In these ads, well-heeled and relatively fancy white people lounged in and around large, ...

Plus, as it is available in three delightful scents (Serene Clean, Fragrance Free, and Beachy Clean), this product is well worth a try in our books! Key ingredients ... the world-renowned ...